Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 635 shares (grant or award)
  2. 4 Grant or award Director acquired 1,271 shares (grant or award)
  3. 4 Open-market sale President & CEO sold 100,000 shares at $10.38 ($1,038,000)
  4. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  5. 4 Grant or award Chief Legal Officer acquired 34,000 shares (grant or award)
  6. 4 Grant or award Chief R&D Officer acquired 81,000 shares (grant or award)
  7. 4 Grant or award President & CEO acquired 127,500 shares (grant or award)
  8. 4 Grant or award Exec. Director, Finance - PAO acquired 5,900 shares (grant or award)
  9. 4 Grant or award Chief Commercial Officer acquired 34,000 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 34,000 shares (grant or award)
  11. 4 Open-market sale President & CEO sold 14,100 shares at $10.90 ($153,690)
  12. 4 Open-market sale Chief R&D Officer sold 3,125 shares at $10.89 ($34,031)
  13. 4 Open-market sale Chief Financial Officer sold 5,700 shares at $10.90 ($62,130)
  14. 4 Open-market sale Chief Commercial Officer sold 6,100 shares at $10.90 ($66,490)
  15. 4 Open-market sale Exec. Director, Finance - PAO sold 445 shares at $10.90 ($4,851)
  16. 4 Open-market sale Chief Legal Officer sold 4,175 shares at $10.88 ($45,424)
  17. 4 Open-market sale Exec. Director, Finance - PAO sold 8,600 shares at $13.01 ($111,886)
  18. 4 Open-market sale President & CEO sold 297,573 shares at an average $12.94 ($3,851,918)
  19. 4 Grant or award Director acquired 421 shares (grant or award)
  20. 4 Grant or award Director acquired 421 shares (grant or award)

Page 8 of 49 · 965 filings